These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6800954)

  • 21. [Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine].
    Golovina LI; Kuvakina VI; Alliluev AP; Basnak'ian IA; Sivko RI
    Klin Lab Diagn; 1995; (1):26-9. PubMed ID: 7757362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
    Fijen CA; Kuijper EJ; Drogari-Apiranthitou M; Van Leeuwen Y; Daha MR; Dankert J
    Clin Exp Immunol; 1998 Dec; 114(3):362-9. PubMed ID: 9844044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary and Serum Antibody Response Against Neisseria meningitidis After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers.
    Bårnes GK; Workalemahu B; Kristiansen PA; Beyene D; Merdekios B; Fissiha P; Aseffa A; Caugant DA; Naess LM
    Scand J Immunol; 2016 Aug; 84(2):118-29. PubMed ID: 27219622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.
    Ambrosch F; Wiedermann G; Crooy P; George AM
    Bull World Health Organ; 1983; 61(2):317-23. PubMed ID: 6407768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children.
    King WJ; MacDonald NE; Wells G; Huang J; Allen U; Chan F; Ferris W; Diaz-Mitoma F; Ashton F
    J Pediatr; 1996 Feb; 128(2):196-202. PubMed ID: 8636811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.
    Pichichero M; Casey J; Blatter M; Rothstein E; Ryall R; Bybel M; Gilmet G; Papa T
    Pediatr Infect Dis J; 2005 Jan; 24(1):57-62. PubMed ID: 15665711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers.
    Glode MP; Lewin EB; Sutton A; Le CT; Gotschlich EC; Robbins JB
    J Infect Dis; 1979 Jan; 139(1):52-9. PubMed ID: 108338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
    J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
    Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
    Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.
    Rennels M; King J; Ryall R; Papa T; Froeschle J
    Pediatr Infect Dis J; 2004 May; 23(5):429-35. PubMed ID: 15131466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.
    Gheesling LL; Carlone GM; Pais LB; Holder PF; Maslanka SE; Plikaytis BD; Achtman M; Densen P; Frasch CE; Käyhty H
    J Clin Microbiol; 1994 Jun; 32(6):1475-82. PubMed ID: 8077392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants.
    Fairley CK; Begg N; Borrow R; Fox AJ; Jones DM; Cartwright K
    J Infect Dis; 1996 Dec; 174(6):1360-3. PubMed ID: 8940235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides.
    Peltola H; Safary A; Käyhty H; Karanko V; André FE
    Pediatrics; 1985 Jul; 76(1):91-6. PubMed ID: 3925430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses to meningococcal polysaccharide vaccines.
    Brandt BL; Artenstein MS; Smith CD
    Infect Immun; 1973 Oct; 8(4):590-6. PubMed ID: 4200543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
    Joseph H; Balmer P; Bybel M; Papa T; Ryall R; Borrow R
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):1-5. PubMed ID: 14715537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.
    Keyserling H; Papa T; Koranyi K; Ryall R; Bassily E; Bybel MJ; Sullivan K; Gilmet G; Reinhardt A
    Arch Pediatr Adolesc Med; 2005 Oct; 159(10):907-13. PubMed ID: 16203934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.
    Selander B; Käyhty H; Wedege E; Holmström E; Truedsson L; Söderström C; Sjöholm AG
    J Clin Immunol; 2000 Mar; 20(2):138-49. PubMed ID: 10821465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.